Catalyst Wire Dossier Catalyst Wire Dossier

DICLOFENAC SODIUM

DICLOFENAC SODIUM · Padagis Israel Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

120 regulatory and trial events tracked for DICLOFENAC SODIUM, covering 2006-07-28 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Evaluation of Intraligamentary Injection of Dexamethasone, Diclofenac Sodium, and Chymotrypsin for Enhancing the Success of 4% Articaine Buccal Infiltration in Mandibular Molars With Symptomatic Irreversible Pulpitis [Phase 4]

See pricing